UNSPSC 85812213: Introduction of monoclonal antibody into lower gi, via natural or artificial opening endoscopic

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 85812213

Definition

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of monoclonal antibody into lower gi, via natural or artificial opening endoscopic. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0H80M

About UNSPSC 85812213

UNSPSC 85812213 Introduction of monoclonal antibody into lower GI via natural or artificial opening endoscopic is a Commodity code with minimal recent state and local procurement activity aligned to its nominal scope. The code appears designed for a specific clinical procedure — endoscopic delivery of monoclonal antibody therapy to the lower gastrointestinal tract — yet the recent opportunities tagged under it span telehealth urgent care, broad medical services, nursing home operations, cancer screening, medical director services, occupational health, employee wellness, and opioid use disorder treatment. None of these solicitations involve gastrointestinal monoclonal antibody infusion or endoscopic procedures, indicating either a tagging mismatch or the code's use as a catch-all healthcare services classifier in state procurement systems.

State and local buyers tagging opportunities under this code include county health authorities, county behavioral health departments, county sheriffs' offices, municipal health systems, county purchasing offices, state health agencies, and school districts across California, Georgia, Nevada, Colorado, Florida, Arizona, New York, Oregon, Texas, Kansas, Virginia, Illinois, and other states. The issuing bodies span every traditional government tier. Representative recent opportunities include the Nevada Health Authority's PACE program RFP (proposals due December 10, 2026) soliciting operators for statewide elderly care coordination; San Mateo Medical Center's Cancer Registry Services RFP (proposals due November 6, 2026) seeking case abstractors and coding personnel; the Boulder County Sheriff's Office's EMT staffing RFP for jail medical services (proposals due October 26, 2026); and the City of Ocala's Employee Health Clinic Services RFP (proposals due April 20, 2026) seeking primary and occupational health management for municipal staff. The code shows activity across California, Nevada, Colorado, Florida, Arizona, Georgia, New York, Oregon, Texas, and additional states. The pattern indicates the code is functioning as a miscellaneous healthcare services classifier rather than tracking endoscopic monoclonal antibody therapy; vendors pursuing this code should confirm scope alignment with individual issuing bodies rather than relying on the code name alone.

Quick answers

What is UNSPSC 85812213?

UNSPSC 85812213 is Introduction of monoclonal antibody into lower gi, via natural or artificial opening endoscopic, a commodity in UNSPSC 85000000, Healthcare Services.

Which NIGP codes match UNSPSC 85812213?

UNSPSC 85812213 maps to 1 NIGP code, 94848 Health Care Services (Not Otherwise Classified).

On GovTribe

See everything under UNSPSC 85812213

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code